APTIMMUNE
Aptimmune is a biotechnology company that focuses on developing a muscoal vaccine against viral diseases swine. It focuses on swine vaccines and the prevention of two major diseases, Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza. It utilizes novel technologies to create effective nasal delivery vaccines against PRRSV such as the proprietary pig alveolar macrophage cell line ZMAC. The company was founded in 2010 and headquartered in St. Louis, Missouri.
APTIMMUNE
Industry:
Biopharma Biotechnology Health Care Health Diagnostics Test And Measurement
Founded:
2010-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Website Url:
http://www.aptimmune.com
Total Employee:
1+
Status:
Active
Contact:
2173334050
Email Addresses:
[email protected]
Total Funding:
8.85 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Font API WordPress Google Analytics Google Universal Analytics Sitelinks Search Box Yoast WordPress SEO Plugin Yoast Plugins
Similar Organizations
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Stingray Bio
Stingray Bio is ab biotechnology company that targets LMTK3 kinase to develop precision therapeutics for treating cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Yield Lab Asia Pacific
The Yield Lab Asia Pacific investment in Convertible Note - Aptimmune
Kemin Industries
Kemin Industries investment in Corporate Round - Aptimmune
Missouri Technology Corporation
Missouri Technology Corporation investment in Series B - Aptimmune
St. Louis Arch Angels
St. Louis Arch Angels investment in Series B - Aptimmune
Cultivation Capital
Cultivation Capital investment in Series B - Aptimmune
Arsenal Capital Management
Arsenal Capital Management investment in Series B - Aptimmune
The Yield Lab
The Yield Lab investment in Series B - Aptimmune
The Yield Lab
The Yield Lab investment in Convertible Note - Aptimmune
Fox Ventures
Fox Ventures investment in Series A - Aptimmune
Illinois Ventures
Illinois Ventures investment in Series A - Aptimmune
Official Site Inspections
http://www.aptimmune.com
- Host name: 196.109.196.104.bc.googleusercontent.com
- IP address: 104.196.109.196
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Aptimmune"
Aptimmune - Crunchbase Company Profile & Funding
Aptimmune is a biotechnology company that focuses on developing a muscoal vaccine against viral diseases swine. It focuses on swine vaccines and the prevention of two major diseases, …See details»
Our Team - Aptimmune
Board of Directors. The Aptimmune board of directors consists of 7 members which includes Federico Zuckermann and Vaibhav Nagpal (CEO), with the addition of highly regarded …See details»
Aptimmune Biologics - Org Chart, Teams, Culture & Jobs - The Org
View Aptimmune Biologics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Aptimmune Company Profile 2024: Valuation, Funding & Investors …
Aptimmune General Information Description. Developer of novel swine mucosal vaccines designed to offer effective protection from viral diseases. The company's vaccines address …See details»
Aptimmune Biologics, Inc. Company Profile | Saint Louis, MO ...
Find company research, competitor information, contact details & financial data for Aptimmune Biologics, Inc. of Saint Louis, MO. Get the latest business insights from Dun & Bradstreet.See details»
Aptimmune Biologics - Company Profile - Tracxn
Dec 9, 2024 Aptimmune Biologics. has raised a total funding of $11M over 5 rounds. Its first funding round was on Jul 09, 2015. What are the most recent funding rounds of Aptimmune …See details»
Aptimmune Company Profile - Office Locations, Competitors
Aptimmune has 5 employees across 4 locations and $8.85 m in total funding,. See insights on Aptimmune including office locations, competitors, revenue, financials, executives, …See details»
Aptimmune Biologics' Leadership Team - Team members and org …
The leadership team at Aptimmune Biologics has experience in the medical and pharmaceutical industries, as well as in owning and operating their own businesses. They have also studied …See details»
Aptimmune Completes $6 Million Series B Funding, Moves …
Jan 23, 2018 St. Louis, Mo. (January 22, 2018) – Aptimmune Biologics announces it has completed its Series B funding initiative, raising more than $6 million from several investors. …See details»
Aptimmune Biologics - Overview, News & Similar companies
Aug 6, 2018 Who is Aptimmune Biologics. Aptimmune Biologics, St. Louis, Mo., specializes in developing and marketing a portfolio of revolutionary mucosal vaccines that provide answers …See details»
APTIMMUNE BIOLOGICS, INC. Information - RocketReach
The NAICS codes for APTIMMUNE BIOLOGICS, INC. are [325414, 32541, 32, 325, 3254]. What is the SIC code for APTIMMUNE BIOLOGICS, INC.? The SIC codes for APTIMMUNE …See details»
Aptimmune - Updates, News, Events, Signals & Triggers
Aptimmune is a biotechnology company that specializes on developing mucosal vaccines for swine.See details»
Aptimmune - Contacts, Employees, Board Members, Advisors
Organization. Aptimmune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... including Founder & Chief Scientific Officer Federico …See details»
Aptimmune Biologics - VentureRadar
Aptimmune Biologics specializes in the development and application of prophylactic measures against viral diseases of swine. Our current focus is bringing into the market effective …See details»
Aptimmune Biologics adds CEO and technical consultant
Jan 8, 2019 Aptimmune Biologics announces the addition of two members to the company’s management team to start the new year. Heather Bessoff, DVM, has joined the company as …See details»
Vaccine manufacturer could turn the tide on ASF - AgUpdate
Sep 28, 2020 Aptimmune Biologics Inc., a St. Louis, Missouri-based biotechnology company that focuses on developing swine vaccines, has been working on an ASF vaccine for more …See details»
Aptimmune - Tech Stack, Apps, Patents & Trademarks - Crunchbase
The intellectual property of Aptimmune includes 2 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, Aptimmune has …See details»
Join Our Team - Aptimmune
Aptimmune Biologics specializes in developing revolutionary mucosal vaccines that provide unsurpassed efficacy against the viral diseases most costly to the swine industry. We focus …See details»
Barricade Showcase - Aptimmune
Aptimmune’s patented porcine macrophage cell line, ZMAC, is a unique cornerstone in our Barricade Technology Platform. ZMAC is a scalable cell line that specializes in efficiently …See details»